Clinical significance of FBXW7 loss of function in human cancers

J Fan, M Bellon, M Ju, L Zhao, M Wei, L Fu, C Nicot - Molecular cancer, 2022 - Springer
Abstract FBXW7 (F-Box and WD Repeat Domain Containing 7)(also referred to as FBW7 or
hCDC4) is a component of the Skp1-Cdc53/Cullin-F-box-protein complex (SCF/β-TrCP). As …

Molecular biomarkers in acute myeloid leukemia

J Prada-Arismendy, JC Arroyave, S Röthlisberger - Blood reviews, 2017 - Elsevier
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. The
pathophysiology of this disease is just beginning to be understood at the cellular and …

Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC

T Donyavi, F Bokharaei-Salim, HB Baghi… - International …, 2021 - Elsevier
Background When a new pathogen, such as severe acute respiratory syndrome coronavirus
2, appears all novel information can aid in the process of monitoring and in the diagnosis of …

Nanomedicines for the treatment of hematological malignancies

AK Deshantri, AV Moreira, V Ecker… - Journal of Controlled …, 2018 - Elsevier
Hematological malignancies (HM) are a collection of malignant transformations originating
from cells in the primary or secondary lymphoid organs. Leukemia, lymphoma, and multiple …

Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid

M Karami Fath, J Azami, N Jaafari… - Cellular & Molecular …, 2022 - Springer
Exosomes, known as a type of extracellular vesicles (EVs), are lipid particles comprising
heterogeneous contents such as nucleic acids, proteins, and DNA. These bi-layered …

MicroRNA as a novel biomarker in the diagnosis of head and neck cancer

J Kabzinski, M Maczynska, I Majsterek - Biomolecules, 2021 - mdpi.com
Head and neck squamous cell carcinoma is the sixth most common cancer worldwide, with
890,000 new cases and 450,000 deaths in 2018, and although the survival statistics for …

MicroRNA in leukemia: Tumor suppressors and oncogenes with prognostic potential

R Mardani, MH Jafari Najaf Abadi… - Journal of cellular …, 2019 - Wiley Online Library
Leukemia is known as a progressive malignant disease, which destroys the blood‐forming
organs and results in adverse effects on the proliferation and development of leukocytes and …

MicroRNAs as biomarkers for clinical studies

IP Pogribny - Experimental Biology and Medicine, 2018 - journals.sagepub.com
The development of better diagnostic and prognostic non-invasive biomarkers holds an
enormous potential to improve the ability to diagnose and individualize treatment of a great …

Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance

AA Bhat, SN Younes, SS Raza, L Zarif, S Nisar… - Molecular cancer, 2020 - Springer
Early-stage detection of leukemia is a critical determinant for successful treatment of the
disease and can increase the survival rate of leukemia patients. The factors limiting the …

Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state

A Ng, F Lovat, AJ Shih, Y Ma… - Proceedings of the …, 2023 - National Acad Sciences
Dysregulated apoptosis and proliferation are fundamental properties of cancer, and
microRNAs (miRNA) are critical regulators of these processes. Loss of miR-15a/16-1 at …